Supplements for Fatty Liver: What the Trials Show, and What Diet Does Better

Most people learn they have fatty liver by accident, from an ultrasound ordered for something else or a blood test showing a raised ALT. The first question is almost always whether it can be fixed without a prescription. The honest answer is that the biggest lever sits nowhere near the supplement aisle.

What Fatty Liver (MASLD) Actually Is

Fatty liver means fat has built up inside the liver cells, and its medical name is now MASLD. It ranges from harmless fat to an inflamed liver with early scarring.

Older research calls this NAFLD, for non-alcoholic fatty liver disease. In 2023, liver societies replaced that name with MASLD, metabolic dysfunction-associated steatotic liver disease, to drop the word "alcoholic" and tie the diagnosis to metabolic health.

There are two stages:

• Steatosis. Fat is present. Most people sit here, and it often improves.
• Steatohepatitis, or NASH. Inflammation joins the fat. This can lead to scarring, called fibrosis.

The stage matters more than the amount of fat.

How Common It Is, and Why It Stays Silent

Roughly 30% of adults worldwide have fatty liver, and the number keeps climbing. A review of 92 studies covering more than 9.3 million people put global prevalence at 30.05%, up about 50% from 25.26% in 1990-2006 to 38.00% by 2016-2019.

It is usually silent because the liver itself has no pain fibers. You can carry a lot of fat and feel nothing, so a routine scan or blood test is often the first clue.

The Weight Loss Number That Does More Than Any Supplement

Start here. For anyone searching how to reverse fatty liver, weight loss is the lever with the most evidence.

Researchers followed 293 people with biopsy-proven NASH through 52 weeks of lifestyle change. The 88 who lost at least 5% of body weight did far better: 58% had their steatohepatitis resolve, and 82% saw their activity score drop two points. Among those who lost 10% or more, 90% had resolution and 45% had fibrosis regress. That is a direct, dose-dependent link between how much weight was lost and whether scarring improved.

Across the whole group, 25% had resolution and 19% had fibrosis regress. The trial numbers line up with clinical practice guidance: 5% helps liver fat, and 10% or more gives the best chance with inflammation and fibrosis.

The 12-week TANGO trial shows how fast a diet works. In 88 women with fatty liver, a Mediterranean-style diet produced a 4.5% weight loss and a 30% drop in liver fat on MRI, against 10% in controls.

No supplement here comes close to what a 5% to 10% body weight loss does.

The Fatty Liver Diet: What to Eat and What to Cut

Here is the short answer to what to eat and avoid with fatty liver.

Eat more:

• Vegetables and leafy greens.
• Beans, lentils, and other legumes.
• Whole grains such as oats, barley, and quinoa.
• Fatty fish, nuts, seeds, olive oil, and avocado.
• Eggs, unsweetened dairy, coffee, and unsweetened tea.

Cut back on:

• Sugary drinks: soda, sweet tea, most juice.
• Sweets and desserts with added sugar.
• Refined white bread, white rice, pastries.
• Processed meats and alcohol.

The Fructose Question, Answered Honestly

You have probably read that fructose causes fatty liver. It is processed in the liver, and a large load gives it material to turn into fat. A 2022 meta-analysis found the harm tracks extra calories and the food source. The sugar that hurts most is the sugar you drink. Whole fruit comes with fiber and is not the problem.

Coffee: The One Drink Worth Keeping

A pooled analysis of five studies found coffee drinkers had a lower risk of fatty liver, a risk ratio of 0.71 (95% CI 0.60 to 0.85), and of fibrosis at 0.70. Keep the coffee, drop the sugar.

The Mediterranean Pattern: A Mixed Result

The Mediterranean diet earns its place, but the pooled numbers are mixed. A meta-analysis of 10 trials found a significant drop in total cholesterol (p=0.001). Liver stiffness fell 0.42 kPa, not statistically significant (p=0.10), and liver enzymes and waist did not change.

Exercise and Sleep: Two Levers People Skip

Diet gets the attention, but movement and sleep do part of the work.

Exercise helps even when the scale does not move. Aim for about 150 minutes a week of moderate activity, such as brisk walking, plus two resistance sessions. If you have not been active, start with a 10-minute walk after dinner.

Obstructive sleep apnea is common in people with fatty liver, so ask about a sleep study if you snore heavily or wake tired. Seven to nine hours is the target, not a luxury.

Supplements for Fatty Liver: What the Trials Actually Show

Liver fat and liver inflammation are different targets, and a supplement can move one without touching the other. For supplements for fatty liver, read the grade as strength of evidence.

Vitamin E: The Strongest Signal

The PIVENS trial gave 247 adults with NASH 800 IU of vitamin E daily for 96 weeks. NASH improved in 43% versus 19% on placebo (P=0.001). The trial enrolled people without diabetes, and high-dose vitamin E has a safety question. The dose was 800 IU daily, supervised.

Omega-3: Moves Fat, Not Inflammation

A review of 18 studies found long-chain omega-3 fats improved 6 of 13 metabolic risk factors, 2 of 3 liver enzymes, liver fat on MRI, and steatosis on ultrasound. In people who already had NASH, omega-3 did not change inflammation or scarring.

Milk Thistle: The Honest Split

A 2024 review of 26 trials and 2,375 patients found silymarin lowered liver damage markers on blood tests. The largest NASH trial, 700 mg three times daily for 48 weeks in 99 patients, missed its primary outcome. The pooled data found lower liver enzymes and better steatosis on biopsy (OR 3.25, 95% CI 1.80 to 5.87), but the largest single NASH trial still missed its primary outcome.

Berberine: Lower ALT, No Fat Advantage

A randomized, double-blind trial gave 70 patients 1,500 mg of berberine daily for 12 weeks. ALT fell significantly (p=0.0105), and total cholesterol improved. No other lipid or glucose measure changed, and the trial did not report liver fat as an outcome.

Choline and Betaine

Fat must be packaged to leave the liver, and that package is phosphatidylcholine, built from choline. Short on choline, the liver builds fat. Betaine works the same pathway, as a methyl donor. Dietary adequacy matters, and the supplement evidence is thin. The best test of betaine gave 55 people with biopsy-proven NASH 20 g daily for 12 months and did not improve steatosis, activity score or fibrosis versus placebo (20). So food is the reliable route.

Vitamin D

A meta-analysis of 16 trials found vitamin D raised HDL cholesterol (P=0.008) and reduced body weight, BMI, waist, ALT, fasting blood sugar, and insulin resistance. Triglycerides, total cholesterol, LDL cholesterol, and the other liver enzymes did not change.

What Did Not Work

Grading what fails is how you know the rest of this page is honest.

• Silymarin for liver tissue. The 99-patient trial missed its primary outcome.
• Omega-3 for inflammation and scarring. Fish oil lowered liver fat, but the tissue measures did not budge.
• Berberine for liver fat. The trial did not report liver fat. The only moves were in ALT and total cholesterol.
• Pentadecanoic acid (C15:0) as an add-on. In TANGO the diet did most of the work. Adding C15:0 moved weight loss only from 4.5% to 5.3% and liver fat from 30% to 33%, though it did lower LDL cholesterol further.
• Fiber and inulin-type add-ons. Observational studies link higher fiber intake to lower fatty liver risk, but the supplement forms have not shown a clear win over fiber from food.

It is easier to move a blood test than to move the liver. That is why weight loss sits at the top.

Safety: Vitamin E, Botanicals, and Prescription Interactions

The higher the dose, the more the safety question matters, and this is a category where people dose high.

A 2005 meta-analysis found that high-dosage vitamin E supplementation may increase all-cause mortality. That is why the PIVENS result carries a warning, not a green light.

Herbal and dietary supplements are a growing cause of liver injury, and high-dose green tea extract is one of the better documented culprits (18, 19). That is the strongest argument for adding one thing at a time. Adding four new supplements at once makes it impossible to tell which helped and which hurt.

Berberine and milk thistle can interact with prescription medications, so tell your clinician what you take.

When to Ask for a FIB-4

Most people with fatty liver need no special testing. A smaller group carries the fibrotic stage without knowing it.

FIB-4 is a simple calculation from your age and three routine blood results: AST, ALT, and platelet count. Guidelines use it to sort low-risk from higher-risk people, and a higher score points to further testing, such as a liver stiffness scan.

Ask about a FIB-4 if you have fatty liver plus any of these:

• Type 2 diabetes.
• A BMI in the obese range.
• Persistently raised liver enzymes.
• Other features of metabolic syndrome.

If your score is high, ask for a referral to a liver specialist.

What Your Doctor May Now Offer: Resmetirom

For the first time, there is an approved drug for the fibrotic stage.

Resmetirom is a once-daily pill that targets the liver directly. In a phase 3 trial, the 80 mg and 100 mg doses cut liver fat by 34.9% and 38.6% at 16 weeks (P<0.0001). LDL cholesterol fell 11.1% and 12.6%, triglycerides fell 15.4% and 20.4%, and liver stiffness dropped. It was safe and well tolerated, with diarrhea and nausea more common than placebo at the start.

A second phase 3 trial tested it in people who already had liver fibrosis. It is a prescription for a defined group, chosen by a clinician, not a reason to stop the diet and exercise work.

Your First 90 Days: A Starting Plan

You need a sequence you can hold.

1. Book the baseline. Liver enzymes, a lipid panel, fasting glucose, and a hemoglobin A1c. Ask for a FIB-4 if you have risk factors.
2. Cut liquid sugar first. Soda, sweet tea, and juice are the fastest change with the clearest payoff.
3. A 5% weight loss is a reasonable first target. From 200 pounds, that is 10 pounds.
4. Rebuild your plate. Vegetables in volume, a protein at each meal, whole grains over refined.
5. Move 150 minutes a week, split into walks you will take, plus two resistance sessions.
6. Protect 7 to 9 hours of sleep. Ask about a sleep study if you snore or wake tired.
7. Add supplements one at a time, with your clinician, and give each 12 weeks.
8. Recheck at day 90. New blood work tells you more than how you feel.

Start with steps 1 through 3.

References

1. Younossi ZM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335-1347. doi:10.1097/HEP.0000000000000004. PMID 36626630.
2. Vilar-Gomez E, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;149(2):367-378. doi:10.1053/j.gastro.2015.04.005. PMID 25865049.
3. Chooi YC, et al. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Am J Clin Nutr. 2024;119(3):788-799. doi:10.1016/j.ajcnut.2023.11.013. PMID 38035997.
4. European Association for the Study of the Liver, et al. EASL-EASD-EASO Clinical Practice Guidelines on the management of MASLD. J Hepatol. 2024. doi:10.1016/j.jhep.2024.04.031. PMID 38851997.
5. Jensen T, et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063-1075. doi:10.1016/j.jhep.2018.01.019. PMID 29408694.
6. Lee D, et al. Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials. Nutrients. 2022;14(14):2846. doi:10.3390/nu14142846. PMID 35889803.
7. Wijarnpreecha K, et al. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(2):e8-e12. doi:10.1097/MEG.0000000000000776. PMID 27824642.
8. Del Bo' C, et al. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in NAFLD Subjects? A Systematic Review and Meta-Analysis of RCTs. Nutrients. 2023;15(10):2250. doi:10.3390/nu15102250. PMID 37242133.
9. Sanyal AJ, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675-1685. doi:10.1056/NEJMoa0907929. PMID 20427778.
10. Musa-Veloso K, et al. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease. Nutr Rev. 2018;76(8):581-602. doi:10.1093/nutrit/nuy022. PMID 29917092.
11. Li S, et al. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis. Ann Hepatol. 2024. doi:10.1016/j.aohep.2023.101174. PMID 38579127.
12. Wah Kheong C, et al. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2017. doi:10.1016/j.cgh.2017.04.016. PMID 28419855.
13. Koperska A, et al. Does berberine impact anthropometric, hepatic, and metabolic parameters in patients with metabolic dysfunction-associated fatty liver disease? Randomized, double-blind placebo-controlled trial. J Physiol Pharmacol. 2024;75(3). doi:10.26402/jpp.2024.3.06. PMID 39042390.
14. Rezaei S, et al. The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With NAFLD: A Systematic Review and Meta-analysis. Front Pharmacol. 2021;12:732496. doi:10.3389/fphar.2021.732496. PMID 34803681.
15. Miller ER 3rd, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37-46. PMID 15537682.
16. Harrison SA, et al. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2023;29(11):2919-2928. doi:10.1038/s41591-023-02603-1. PMID 37845512.
17. Harrison SA, et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024;390(6):497-509. doi:10.1056/NEJMoa2309000. PMID 38324483.
18. Navarro VJ, et al. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363-373. doi:10.1002/hep.28813. PMID 27677775.
19. Teschke R, et al. Green tea extract and the risk of drug-induced liver injury. Expert Opin Drug Metab Toxicol. 2014;10(12):1663-1676. doi:10.1517/17425255.2014.971011. PMID 25316200.
20. Abdelmalek MF, et al. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology. 2009;50(6):1818-1826. doi:10.1002/hep.23239. PMID 19824078.

What We Recommend

Each pick below lines up with something this article graded honestly: milk thistle's blood-test signal, the choline pathway that packages fat for export, and the glutathione and NAC pair the body relies on for antioxidant support. Agape Nutrition stocks each one in a practitioner-grade form, and none of them replaces the 5% to 10% weight loss the evidence points to, so add them one at a time with your clinician.

Frequently Asked Questions